UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated (UNH) carries a ŷRobot AI score of 69 out of 100. The model's fair value estimate is $463.78, 14.0% above the last close of $406.66. The chart signal reads Sell.
| Metric | UNH |
|---|---|
| AI score | 69 / 100 |
| Chart signal | Sell |
| Fair value estimate | $463.78 |
| Upside to fair value | 14.0% |
| Previous close | $406.66 |
| P/E | 24.29 |
| Price / sales | 0.81 |
| Market cap | $365.02B |
| EPS | 16.29 |
| Revenue growth | 10.3% |
| 1-year price change | 5.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, Novartis AG ADR, Thermo Fisher Scientific Inc.
Questions about UNH
Is UNH overvalued or undervalued right now?
As of Oct 15, 2026, ŷRobot's fair-value model estimates UnitedHealth Group Incorporated (UNH) at $463.78 against a last close of $406.66, implying 14.0% upside to the model's estimate.
Is UNH's chart signal bullish or bearish?
The chart-signal model classifies UNH as Neutral as of Oct 15, 2026, with a signal score of -0.09 on a -1 to 1 scale.
What is UNH's ŷRobot AI score?
UNH scores 69 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 15, 2026.
Is UNH stock expensive on P/E and P/S?
UNH trades at 24.3 times earnings and 0.8 times sales as of Oct 15, 2026.
What does UNH's seasonal forecast show?
ŷRobot's seasonal forecast curve for UNH reads +4.1% at 30 days, +3.2% at 90 days, and +5.1% at one year as of Oct 15, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is UNH growing?
UnitedHealth Group Incorporated's revenue growth is +10.3% and free-cash-flow growth is +13.5% on the latest reported figures.
UNH chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.